About Nortis
Nortis is a company based in Woodinville (United States) founded in 2007 was acquired by Quris in October 2024. Nortis has raised $10.66 million across 21 funding rounds from investors including HHS and Quris Ai. The company has 19 employees. Nortis operates in a competitive market with competitors including Emulate, CN Bio, AxoSim, Mimetas and Obatala Sciences, among others.
- Headquarter Woodinville, United States
- Employees 19
- SectorsHealthcare
- Email••••••••
- Website nortisbio.com
- Social LinkedIn X
- Acquired by Quris (Oct 2024)
- Legal Name Nortis Inc
Funding Insights of Nortis
Nortis has successfully raised a total of $10.66M across 21 strategic funding rounds. The most recent funding activity was a Grant round of $275.45 thousand completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $10.66M
- Total Rounds 21
- Last Round Grant — $275,453
- First Round $150,000
(Oct 2007)
- Investors Count 1
Latest 10 of 21 funding rounds of Nortis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2023 | $275,453 | Grant | – | – | |
| Aug 2022 | $6M | Series A | – | – | – |
| Jun 2021 | $1.5M | Seed | – | – | – |
| Jun 2021 | $1M | Debt – Conventional | – | – | – |
| May 2021 | $1.36M | Grant | – | – | |
| Sep 2019 | $300,000 | Grant | – | – | |
| Sep 2019 | $2.64M | Grant | – | – | |
| Jul 2017 | $323,200 | Seed | – | – | – |
| Jun 2017 | $12,500 | Seed | – | – | – |
| Sep 2015 | $1.61M | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Nortis
Nortis has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Quris Ai.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - | |
AI-based drug candidate predicting tool for healthcare professionals | 2020 | quris.ai | - |
Investor details for Nortis
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Nortis
7 people are tracked at Nortis (4 in leadership, 3 in team); the tracked headcount is 19.
| Name | Role | Group |
|---|---|---|
John Williford | Director of Biomanufacturing and Contract Research | Leadership |
Sepand Bafti | Director of Biological Science | Leadership |
Stacy Martin | Scientific Project Director | Leadership |
Thomas Neumann | Chief Scientific Officer | Leadership |
Ryan LaRock | Production And Inventory Control Manager | Team |
Samantha Kuhn-Arnold | Research Technician | Team |
Rebecca K Booth | Research Technician & Lab Manager | Team |
Complete people profiles for Nortis
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Nortis
4 dated milestones of Nortis across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Nortis is founded.
- Funding First funding round of $150K.
- Funding Latest funding round, Grant, of $275K.
- Exit Acquired by Quris.
Competitors of Nortis
Nortis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Emulate, CN Bio, AxoSim, Mimetas and Obatala Sciences, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| emulatebio.com | 2013 | Boston, United States | $204.49M | 93 | Developer of in vitro models for drug development | |
| cn-bio.com | 2009 | Cambridge, United Kingdom | $44.78M | 33 | Organ-on-a-chip platforms are developed for drug discovery applications. | |
| axosim.com | 2014 | New Orleans, United States | $6.78M | 27 | Nerve-on-a-chip technology is advanced by AxoSim for drug development improvement. | |
| mimetas.com | 2013 | Leiden, Netherlands | $28.9M | – | Microfluidics-based organ-on-a-chip models for drug evaluation are developed. | |
| obatalasciences.com | 2017 | New Orleans, United States | $3.54M | 10 | Provider of research enabling products and services to research centers | |
| netri.com | 2018 | Lyon, France | $8.89M | – | Microfluidic devices are developed for industrial applications and brain-on-a-chip models. | |
| mepsgen.com | 2019 | Seoul, South Korea | $29.26M | – | Developer of human organ model chips for pharmaceutical development | |
| hesperosinc.com | 2015 | Orlando, United States | – | 15 | Organ-on-a-chip solutions for preclinical testing are developed. | |
| tissuse.com | 2010 | Berlin, Germany | – | 31 | Multi-organ chip platform for tissue culture is developed. |
Detailed competitors of Nortis
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nortis
Complete news archive for Nortis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Nortis
10 companies that operate in the same segment as Nortis (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Nortis
Nortis was founded in 2007.
Nortis is headquartered in Woodinville, United States. It is registered at Woodinville, Washington, United States.
Nortis is a funded company, having raised a total of $10.66M across 21 funding rounds to date. The company's 1st funding round was a Grant of $1.61M, raised on Oct 2007.
Nortis has 19 employees.
Nortis was founded in 2007 in Woodinville, United States, within the biotechnology sector. A platform is developed for creating small segments of human tissues and organs using microfluidic chips. The ParVivoTM system is offered as a pre-seeded chip platform, enabling microphysiological environments for in vitro biomedical research and drug discovery applications. Operations focus on supporting research and development in these areas.
Nortis operates through Nortis Inc.
Yes. Nortis was acquired by Quris in October 2024.